NYSE · Surgical & Medical Instruments & Apparatus
29 entities across 20 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-05-20 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| D Information Management, Inc. | Delaware | |
| Advanced Cooling Therapy, LLC | Delaware | |
| Arryx, Inc. | Nevada | |
| Cardiva Medical, Inc. | Delaware | |
| Enicor GmbH | Germany | |
| Global Med Technologies, Inc. | Colorado | |
| Haemonetics (Hong Kong) Limited | Hong Kong | |
| Haemonetics Asia UK Ltd. | United Kingdom | |
| Haemonetics CZ, spol. s.r.o. | Czech Republic | |
| Haemonetics France S.a.r.l | France | |
| Haemonetics GmbH | Germany | |
| Haemonetics Handelsgesellschaft m.b.H. | Austria | |
| Haemonetics Healthcare India Private Limited | India | |
| Haemonetics Interventional Technologies Limited | Ireland | |
| Haemonetics Italia s.r.l. | Italy | |
| Haemonetics Japan GK | Japan | |
| Haemonetics Limited | United Kingdom | |
| Haemonetics Malaysia Sdn. Bhd. | Malaysia | |
| Haemonetics Manufacturing, Inc. | Delaware | |
| Haemonetics Mexico Manufacturing, S.de R.L. de C.V. | Mexico | |
| Haemonetics New Zealand Limited | New Zealand | |
| Haemonetics S.A. | Switzerland | |
| Haemonetics Singapore Pte. Ltd. | Singapore | |
| Haemoscope Corporation | Massachusetts | |
| OpSens B.V. | Netherlands | |
| OpSens Medical, Inc. | Delaware | |
| Vivasure Medical Limited | Ireland | |
| Vivasure Medical UK Ltd. | United Kingdom | |
| Vivasure Medical US, Inc. | Delaware |
Two standard screens, computed from the XBRL in FY2026 against FY2025. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2021 | — | $79.5M | $71.8M | — | 51,292,000 |
| FY2022 | $993.2M | $43.4M | $75.8M | 50.9% | 51,353,000 |
| FY2023 | $1.2B | $115.4M | $162.9M | 52.6% | 51,420,000 |
| FY2024 | $1.3B | $117.6M | $115.5M | 52.8% | 51,397,000 |
| FY2025 | $1.4B | $167.7M | $142.4M | 55.0% | 50,730,000 |
| FY2026 | $1.3B | $97.3M | $260.4M | 59.0% | 47,354,000 |
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
HAEMONETICS CORP files under SIC 3841 — all 38 surgical & medical instruments & apparatus companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
